31
March
2016


Share on networks

• The number of patent applications submitted from Catalonia made up 33.8% of the Spanish total/strong>

• The leading patent applicants include various pharmaceutical laboratories

 

Catalan companies, universities and hospitals lead the ranking of patent applications submitted in Spain. Likewise, Catalonia submits more patent applications than other countries like the Czech Republic, Norway, Portugal, Slovenia, Hungary and Greece, among others, according to data the European Patent Office (EPO) presented recently in Brussels.

In 2014, 515 patent applications were submitted from Spain, making up 33.8% of the 1,525 applications in Spain, ahead of Madrid (24%; 360) and the Basque Country (13%; 199). The report highlights that 350 applications were submitted from the city of Barcelona alone. The fields from which most applications are received include pharmaceutical products, transport and biotechnology.

According to the EPO, Catalonia is home to an innovative business fabric, above all in the pharmaceutical sector, and proof of this can be seen in the fact that the top three patent applicants are Laboratoris Esteve, leading the Catalan ranking with 23 applications in 2015, followed by the Autonomous University of Barcelona (UAB) and Laboratoris Almirall. Also noteworthy are pharmaceutical companies Galenicum, Lesvi, Interquim and Grífols, and among universities and research centers, Barcelona-based universities Polytechnic University of Catalonia (UPC) and Pompeu Fabra (UPF), and the Bellvitge Biomedical Research Institute and the Hospital.

In terms of progression, the number of patent applications in Catalonia was up 5.7% last year from the 487 registered in 2014. This growth is 19 times greater than the EU average, where the figure only rose 0.3%.

 

Share on networks

Related news

Red de conexión 5G en el Puerto de Barcelona

News

The Port of Barcelona, ​​a leading project thanks to the new 5G network

Crecimiento del sector logístico en 2024

News

Catalonia’s logistics market boosted during the second quarter of 2024